A new angel investment group created to leverage cross-border opportunities in early stage life science and healthcare. Will focus on US-based life science and healthcare companies with China/Asia as a key component of their business strategy. Seed or Series A funding of $250K to $1M. Access to government and VC follow-on funding in China. No fee to apply or present, but subject to screening process approval.